Authors :
Dr. Gayathri J.; Dr. Jayashree D. Kulkarni
Volume/Issue :
Volume 9 - 2024, Issue 1 - January
Google Scholar :
http://tinyurl.com/yc6nkjub
Scribd :
http://tinyurl.com/5dzujwp6
DOI :
https://doi.org/10.5281/zenodo.10518143
Abstract :
Hairy cell leukemia variant (HCLv) / Splenic B
cell-lymphoma/leukemia with prominent nucleoli
(SBLPN) is a more aggressive disease, refractory to
standard therapy. Molecular evaluation does not reveal
BRAFp.V600E mutation unlike classic HCL.
Keywords :
Hairy Cell Leukemia, Splenic B Cell- Lymphoma/Leukemia with Prominent Nucleoli, Hclv, BRAF.
Hairy cell leukemia variant (HCLv) / Splenic B
cell-lymphoma/leukemia with prominent nucleoli
(SBLPN) is a more aggressive disease, refractory to
standard therapy. Molecular evaluation does not reveal
BRAFp.V600E mutation unlike classic HCL.
Keywords :
Hairy Cell Leukemia, Splenic B Cell- Lymphoma/Leukemia with Prominent Nucleoli, Hclv, BRAF.
